18:52 IST
BSE
Business Update
Neuland Laboratories Business Update
Neuland Laboratories announced the completion of a US FDA inspection at its Unit 3 facility. The regulator issued a Form 483 with one procedural observation.
Neuland Laboratories Ltd
- Share price
- ₹21,655.00
- Market cap
- ₹27,783 Cr
- Revenue (annual)
- ₹2,023 Cr
- Net profit (annual)
- ₹364.0 Cr
- P/E (TTM)
- 55.8×Sector 47.3×
- Promoter holding
- 32.62%-0.01% QoQ
- FII holding
- 21.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 5Other Announcement 3Financial Results 3Business Update 3Board Meeting Outcome 3Results Update 2Production Started 2Credit Rating 2Capacity Expansion 2Annual General Meeting 2Results Correction 1Management Change 1Dividend 1Debt & Borrowing 1Capital Structure Change 1Board Meeting Date 1Annual Report 1
Time
3 announcements with these filters
13:49 IST
NSE
Business Update
Neuland Laboratories Business Update
Neuland Laboratories reported the loss of a share certificate for shareholder Ram Chander Gupta. The company is processing the issuance of an entitlement letter.
19:40 IST
NSE
Business Update
Neuland Laboratories Business Update
Neuland Laboratories submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance and operational metrics.